These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 7945331

  • 1. In vitro antioxidant activity of calcium antagonists against LDL oxidation compared with alpha-tocopherol.
    Lupo E, Locher R, Weisser B, Vetter W.
    Biochem Biophys Res Commun; 1994 Sep 30; 203(3):1803-8. PubMed ID: 7945331
    [Abstract] [Full Text] [Related]

  • 2. Structure-function relationships of calcium antagonists. Effect on oxidative modification of low density lipoprotein.
    Rojstaczer N, Triggle DJ.
    Biochem Pharmacol; 1996 Jan 26; 51(2):141-50. PubMed ID: 8615882
    [Abstract] [Full Text] [Related]

  • 3. Protection by Ca2+ channel blockers (nifedipine, diltiazem and verapamil) against the toxicity of oxidized low density lipoprotein to cultured lymphoid cells.
    Nègre-Salvayre A, Salvayre R.
    Br J Pharmacol; 1992 Nov 26; 107(3):738-44. PubMed ID: 1472971
    [Abstract] [Full Text] [Related]

  • 4. HDL oxidability and its protective effect against LDL oxidation in Type 2 diabetic patients.
    Sanguinetti SM, Brites FD, Fasulo V, Verona J, Elbert A, Wikinski RL, Schreier LE.
    Diabetes Nutr Metab; 2001 Feb 26; 14(1):27-36. PubMed ID: 11345163
    [Abstract] [Full Text] [Related]

  • 5. Calcium antagonists as inhibitors of in vitro low density lipoprotein oxidation and glycation.
    Sobal G, Menzel EJ, Sinzinger H.
    Biochem Pharmacol; 2001 Feb 01; 61(3):373-9. PubMed ID: 11172743
    [Abstract] [Full Text] [Related]

  • 6. Tetrahydrobiopterin inhibits copper-induced oxidation of low density lipoprotein.
    Sakuma S, Fujimoto Y, Gohda Y, Fujita T.
    Res Commun Mol Pathol Pharmacol; 2000 Feb 01; 107(5-6):397-406. PubMed ID: 11589366
    [Abstract] [Full Text] [Related]

  • 7. The effect of 17beta-estradiol and alpha-tocopherol on the oxidation of LDL cholesterol from postmenopausal women and the minor effect of gamma-tocopherol and melatonin.
    Arteaga E, Rojas A, Villaseca P, Bianchi M.
    Menopause; 2000 Feb 01; 7(2):112-6. PubMed ID: 10746893
    [Abstract] [Full Text] [Related]

  • 8. Contribution of superoxide to reduced antioxidant activity of glycoxidative serum albumin.
    Sakata N, Moh A, Takebayashi S.
    Heart Vessels; 2002 Nov 01; 17(1):22-9. PubMed ID: 12434198
    [Abstract] [Full Text] [Related]

  • 9. The inhibitory effect of endogenous estrogen metabolites on copper-mediated in vitro oxidation of LDL.
    Seeger H, Mueck AO, Lippert TH.
    Int J Clin Pharmacol Ther; 1998 Jul 01; 36(7):383-5. PubMed ID: 9707353
    [Abstract] [Full Text] [Related]

  • 10. Effect of ursodeoxycholic acid on copper induced oxidation of low density lipoprotein.
    Geetha A, Surendran R.
    Pharmazie; 2005 Aug 01; 60(8):609-13. PubMed ID: 16124405
    [Abstract] [Full Text] [Related]

  • 11. [Inhibition effect of soybean isoflavones on the oxidative modification of low-density lipoprotein].
    Yan X, Gu J, Sun C, Liu D.
    Wei Sheng Yan Jiu; 2001 Nov 01; 30(6):346-9. PubMed ID: 12561616
    [Abstract] [Full Text] [Related]

  • 12. Effect of a single oral dose of antioxidant mixture (vitamin E, carotenoids) on the formation of cholesterol oxidation products after ex vivo LDL oxidation in humans.
    Linseisen J, Hoffmann J, Riedl J, Wolfram G.
    Eur J Med Res; 1998 Feb 21; 3(1-2):5-12. PubMed ID: 9512961
    [Abstract] [Full Text] [Related]

  • 13. Isradipine and lacidipine: effects in vivo and in vitro on Trypanosoma cruzi epimastigotes.
    Núñez-Vergara LJ, Squella JA, Bollo-Dragnic S, Marín-Catalán R, Pino L, Díaz-Araya G, Letelier ME.
    Gen Pharmacol; 1998 Jan 21; 30(1):85-7. PubMed ID: 9457486
    [Abstract] [Full Text] [Related]

  • 14. [Effects of alpha-tocopherol and beta-carotene on the oxidized low density lipoprotein induced by Cu2+].
    Cheng X, Cui Y, Chen Y, Zhang X.
    Wei Sheng Yan Jiu; 2000 Jul 21; 29(4):229-31. PubMed ID: 12520927
    [Abstract] [Full Text] [Related]

  • 15. 1,4-Dihydropyridine calcium channel blockers inhibit plasma and LDL oxidation and formation of oxidation-specific epitopes in the arterial wall and prolong survival in stroke-prone spontaneously hypertensive rats.
    Napoli C, Salomone S, Godfraind T, Palinski W, Capuzzi DM, Palumbo G, D'Armiento FP, Donzelli R, de Nigris F, Capizzi RL, Mancini M, Gonnella JS, Bianchi A.
    Stroke; 1999 Sep 21; 30(9):1907-15. PubMed ID: 10471444
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of LDL oxidation and oxidized LDL-induced cytotoxicity by dihydropyridine calcium antagonists.
    Sevanian A, Shen L, Ursini F.
    Pharm Res; 2000 Aug 21; 17(8):999-1006. PubMed ID: 11028948
    [Abstract] [Full Text] [Related]

  • 17. Oxidation and antioxidation of human low-density lipoprotein and plasma exposed to 3-morpholinosydnonimine and reagent peroxynitrite.
    Thomas SR, Davies MJ, Stocker R.
    Chem Res Toxicol; 1998 May 21; 11(5):484-94. PubMed ID: 9585479
    [Abstract] [Full Text] [Related]

  • 18. Antioxidant properties of two novel 2-biphenylmorpholine compounds (EP2306 and EP2302) in vitro and in vivo.
    Tavridou A, Manolopoulos VG.
    Eur J Pharmacol; 2004 Nov 28; 505(1-3):213-21. PubMed ID: 15556155
    [Abstract] [Full Text] [Related]

  • 19. A critical overview of the chemistry of copper-dependent low density lipoprotein oxidation: roles of lipid hydroperoxides, alpha-tocopherol, thiols, and ceruloplasmin.
    Burkitt MJ.
    Arch Biochem Biophys; 2001 Oct 01; 394(1):117-35. PubMed ID: 11566034
    [Abstract] [Full Text] [Related]

  • 20. The hemodynamic effects of lacidipine in anesthetized dogs: comparison with nitrendipine, amlodipine, verapamil, and diltiazem.
    Quartaroli M, Gambini F, Tarter G, Micheli D, Trist DG, Gaviraghi G.
    J Cardiovasc Pharmacol; 1991 Sep 01; 18(3):326-36. PubMed ID: 1720831
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.